CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 64 enrolled
Drug / intervention
T-PRED +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00699803
NCT00699803Phase 2Completed

Study of T-PRED(TM) Compared to Pred Forte(R)

Bausch & Lomb Incorporated·interventional·Posted Jun 18, 2008·Updated Sep 25, 2020

In Brief

A Phase 2 clinical trial evaluating T-PRED and Pred Forte for Cataract. Completed, enrolled 64 participants across 1 site.

Detailed Summary

Study of T-PRED(TM) compared to Pred Forte(R)

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCataract
CountriesUnited States
Collaborators--

Timeline

Phase 2CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJun 18, 2008
Enrollment StartMay 1, 2008
Primary CompletionAug 1, 2008
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 18.0 years ago

Interventions

T-PREDdrug

T-PRED sterile ophthalmic solution

Pred Fortedrug

Pred Forte sterile ophthalmic solution